Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01529827
Title Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

hematologic cancer

Therapies

Melphalan

Methotrexate

Tacrolimus

Mycophenolate mofetil

Fludarabine

Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.